NO179675C - Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse - Google Patents

Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse

Info

Publication number
NO179675C
NO179675C NO923794A NO923794A NO179675C NO 179675 C NO179675 C NO 179675C NO 923794 A NO923794 A NO 923794A NO 923794 A NO923794 A NO 923794A NO 179675 C NO179675 C NO 179675C
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
compositions containing
pyrimidine nucleoside
nucleoside derivatives
group
Prior art date
Application number
NO923794A
Other languages
English (en)
Norwegian (no)
Other versions
NO923794L (no
NO923794D0 (no
NO179675B (no
Inventor
Masakatsu Kaneko
Hitoshi Hotoda
Tomoyuki Shibata
Tomowo Kobayashi
Yoshihiro Mitsuhashi
Akira Matsuda
Takuma Sasaki
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO923794D0 publication Critical patent/NO923794D0/no
Publication of NO923794L publication Critical patent/NO923794L/no
Publication of NO179675B publication Critical patent/NO179675B/no
Publication of NO179675C publication Critical patent/NO179675C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO923794A 1991-09-30 1992-09-30 Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse NO179675C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25201591 1991-09-30

Publications (4)

Publication Number Publication Date
NO923794D0 NO923794D0 (no) 1992-09-30
NO923794L NO923794L (no) 1993-03-31
NO179675B NO179675B (no) 1996-08-19
NO179675C true NO179675C (no) 1996-11-27

Family

ID=17231394

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923794A NO179675C (no) 1991-09-30 1992-09-30 Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse

Country Status (24)

Country Link
US (1) US5691319A (de)
EP (1) EP0536936B1 (de)
JP (1) JP2569251B2 (de)
KR (1) KR100255491B1 (de)
CN (1) CN1033227C (de)
AT (1) ATE141281T1 (de)
AU (1) AU654212B2 (de)
BR (1) BR1100621A (de)
CA (1) CA2079413C (de)
CZ (1) CZ289477B6 (de)
DE (1) DE69212759T2 (de)
DK (1) DK0536936T3 (de)
ES (1) ES2093211T3 (de)
FI (1) FI105556B (de)
GR (1) GR3020893T3 (de)
HK (1) HK204296A (de)
HU (2) HU221812B1 (de)
IL (1) IL103301A (de)
MX (1) MXPA92005623A (de)
NO (1) NO179675C (de)
NZ (1) NZ244574A (de)
RU (1) RU2085557C1 (de)
TW (1) TW205042B (de)
ZA (1) ZA927474B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817799A (en) * 1990-07-23 1998-10-06 The United States Of America As Represented By The Department Of Health And Human Services 2'-Fluorofuranosyl derivatives and methods for preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
GB9515279D0 (en) * 1995-07-25 1995-09-20 Norsk Hydro As Improved therapeutic agents
CN1050846C (zh) * 1995-08-03 2000-03-29 中国医学科学院医药生物技术研究所 一种抗肿瘤抗生素云南霉素及其制备方法
KR100483256B1 (ko) * 1997-01-24 2005-04-15 콘파마 아에스 젬시타빈 유도체
US6235782B1 (en) 1998-11-12 2001-05-22 Rifat Pamukcu Method for treating a patient with neoplasia by treatment with a platinum coordination complex
US6235776B1 (en) 1998-11-12 2001-05-22 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
AU4430200A (en) * 1999-05-11 2000-11-21 Sankyo Company Limited Liposome preparation of fat-soluble antitumor drug
JP3748536B2 (ja) * 2001-02-09 2006-02-22 三共株式会社 ピリミジンヌクレオシド誘導体の結晶
US6908906B2 (en) 2001-02-09 2005-06-21 Sankyo Company, Limited Crystalline forms of pyrimidine nucleoside derivative
WO2003087119A1 (en) * 2002-04-12 2003-10-23 Achillion Pharmaceuticals, Inc. METHOD FOR SYNTHESIZING β-L-FLUORO-2´,3´DIDEHYDROCYTIDINE (β-L-FD4C)
US20050014716A1 (en) * 2003-05-21 2005-01-20 Wang Jin Wei Pancreatic cancer treatment
GB0328180D0 (en) * 2003-12-04 2004-01-07 Cyclacel Ltd Combination
MY142304A (en) * 2005-01-31 2010-11-15 Taiho Pharmaceutical Co Ltd Novel pyrimidine nucleoside compound or salt thereof
GB0523041D0 (en) 2005-11-11 2005-12-21 Cyclacel Ltd Combination
GB0526419D0 (en) 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
US20100216736A2 (en) 2006-07-21 2010-08-26 Taiho Pharmaceutical Co., Ltd. 2'-cyanopyrimidine nucleoside compound
GB0625283D0 (en) 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US8124593B2 (en) 2007-11-05 2012-02-28 Cyclacel Limited Methods of treatment using sapacitabine
GB2459779A (en) * 2008-05-08 2009-11-11 Cyclacel Ltd Process for the preparation of 2'-cyano-2'-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosylcytosine
GB0808357D0 (en) * 2008-05-08 2008-06-18 Cyclacel Ltd Process
GB0808359D0 (en) * 2008-05-08 2008-06-18 Cyclacel Ltd Process
PL2307002T3 (pl) 2008-06-09 2013-05-31 Cyclacel Ltd Kombinacje sapacytabiny lub cndac z inhibitorami metylotransferazy dna, takimi jak decytabina i prokaina
EP2431376B2 (de) * 2009-05-15 2024-02-07 Delta-Fly Pharma, Inc. Neuer stabiler kristall aus 1-(2'-cyan-2'-desoxy-beta-d-arabinofuranosyl)cytosin-monohydrochlorid
PL2696878T3 (pl) 2011-04-14 2020-01-31 Cyclacel Limited Schemat dawkowania dla sapacytabiny i decytabiny w kombinacji do leczenia ostrej białaczki szpikowej
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
KR102072041B1 (ko) 2011-12-22 2020-01-31 앨리오스 바이오파마 인크. 치환된 뉴클레오사이드, 뉴클레오타이드 및 그의 유사체
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
KR101770246B1 (ko) * 2012-03-28 2017-08-22 후지필름 가부시키가이샤 1-(2-디옥시-2-플루오로-4-티오-β-D-아라비노푸라노실)시토신의 염
JP6286421B2 (ja) 2012-05-15 2018-02-28 サイクラセル リミテッド サパシタビン及びセリシクリブの投与レジメン
WO2016106050A1 (en) * 2014-12-26 2016-06-30 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
JP7149183B2 (ja) 2015-12-03 2022-10-06 バイオサイト リミテッド 癌治療のためのシタラビンコンジュゲート
US12071450B2 (en) 2015-12-03 2024-08-27 Biosight Ltd. Salts of conjugates for cancer therapy
US12064445B2 (en) 2015-12-03 2024-08-20 Biosight Ltd. Cytarabine conjugates for cancer therapy
EP3383883A4 (de) 2015-12-03 2019-07-24 BioSight Ltd. Salze von konjugaten zur krebstherapie
WO2019081951A1 (en) 2017-10-27 2019-05-02 Cyclacel Limited DOSAGE REGIME
RU2020116571A (ru) 2017-12-07 2021-11-22 Эмори Юниверсити N4-гидроксицитидин и производные и связанные с этим противовирусные применения
CN108610384B (zh) * 2018-05-31 2022-02-22 沈阳药科大学 基于肠道mct1载体蛋白设计的前药及其制备方法
WO2021079129A1 (en) 2019-10-24 2021-04-29 Cyclacel Limited Dosing regimen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
EP0151189B1 (de) * 1983-07-20 1990-01-31 Teijin Limited Antineoplastisches mittel
US4818750A (en) * 1985-09-17 1989-04-04 Burroughs Wellcome Co. Treatment of human viral infections
ZA886890B (en) * 1987-10-09 1989-05-30 Hoffmann La Roche Novel dideoxycytidine derivatives
FR2640267B2 (fr) * 1988-01-19 1992-02-14 Univ Paris Curie Procede de synthese de l'azido-3(prime)-desoxy-3(prime)-thymidine et analogues
US4900828A (en) * 1988-05-12 1990-02-13 Hoffmann-Laroche Inc. Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine
FR2632442B1 (fr) * 1988-06-06 1990-09-14 Framatome Sa Dispositif de mesure de parametres dans le coeur d'un reacteur nucleaire en service
EP0348170A3 (de) * 1988-06-21 1990-12-05 Moses Nam Fong Lee Antivirale Pyrimidin-Derivate
FR2635778A1 (fr) * 1988-08-26 1990-03-02 Ire Celltarg Sa Nouveaux derives de la 3(prime) azido-3(prime) deoxythymidine (azt) actifs contre le virus hiv du sida
JPH0678338B2 (ja) * 1988-09-09 1994-10-05 帝人株式会社 ２′，３′−ジデオキシシチジン−２′−エン誘導体、その製造方法及びそれを有効成分とする抗レトロウイルス剤
JP2559917B2 (ja) * 1990-06-15 1996-12-04 三共株式会社 ピリミジンヌクレオシド誘導体

Also Published As

Publication number Publication date
IL103301A (en) 1997-07-13
US5691319A (en) 1997-11-25
CN1072686A (zh) 1993-06-02
FI105556B (fi) 2000-09-15
CZ298592A3 (en) 1993-12-15
EP0536936B1 (de) 1996-08-14
JP2569251B2 (ja) 1997-01-08
JPH05194497A (ja) 1993-08-03
CA2079413C (en) 2003-09-09
EP0536936A1 (de) 1993-04-14
HK204296A (en) 1996-11-15
CA2079413A1 (en) 1993-03-31
CZ289477B6 (cs) 2002-01-16
ZA927474B (en) 1993-07-14
NO923794L (no) 1993-03-31
ES2093211T3 (es) 1996-12-16
KR930006045A (ko) 1993-04-20
FI924381A0 (fi) 1992-09-29
NO923794D0 (no) 1992-09-30
GR3020893T3 (en) 1996-11-30
NO179675B (no) 1996-08-19
ATE141281T1 (de) 1996-08-15
HU211851A9 (en) 1995-12-28
HU9203115D0 (en) 1992-12-28
HU221812B1 (hu) 2003-01-28
AU2602692A (en) 1993-04-01
NZ244574A (en) 1994-01-26
DK0536936T3 (da) 1997-01-13
RU2085557C1 (ru) 1997-07-27
KR100255491B1 (ko) 2000-05-01
DE69212759D1 (de) 1996-09-19
BR1100621A (pt) 1999-12-07
IL103301A0 (en) 1993-02-21
CN1033227C (zh) 1996-11-06
TW205042B (de) 1993-05-01
HUT62310A (en) 1993-04-28
DE69212759T2 (de) 1997-04-03
FI924381A7 (fi) 1993-03-31
MXPA92005623A (es) 2002-06-19
AU654212B2 (en) 1994-10-27

Similar Documents

Publication Publication Date Title
AU654212B2 (en) Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use
NO992549D0 (no) Sukkerforbindelse, geleringsmiddel og fremgangsmÕte for fremstilling derav
SE8804609D0 (sv) Adenosine derivatives
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
UA27220C2 (uk) Спосіб одержання похідних 1-фенілімідазолін-2,5-діону
ES2074719T3 (es) Derivados de nucleosido de pirimidina.
EP0191496A3 (en) Triazine derivatives, a process for preparing the derivatives, and herbicides containing the derivatives as the effective component
DK0609289T3 (da) Imidazolderivater og farmaceutiske præparater med indhold deraf
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
DE69013787D1 (de) Ammonium-verbindung, diese enthaltende zusammensetzung und desinfektionsverfahren.
TW259785B (en) Chemical compounds
EP0598910A4 (de) Verfahren zur herstellung von nukleosidderivaten.
EP0676399A4 (de) Methotrexat-derivate.
AU590793B2 (en) Phenoxy pthalide derivatives
DK480389A (da) Antitumor-aktivt derivat af sf2587, fremgangsmaade til det fremstilling og anticancermiddel indeholdende stoffet
AU632856B2 (en) Novel inosine/guanosine derivatives
CA2244662A1 (en) Antifungal agents
ATE189813T1 (de) Prostaglandin-i-analoga
MY104164A (en) Heterocyclic compounds.

Legal Events

Date Code Title Description
MK1K Patent expired